Immunic (IMUX) Assets Average (2014 - 2026)

Immunic has disclosed Assets Average across 13 years of filings, most recently posting $106.9 million for Q1 2026.

• Assets Average for Q1 2026 came in at $106.9 million, up 248.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $106.9 million (up 248.3% YoY), and the FY2025 annual result was $32.5 million, down 31.78% from the prior year.
• Assets Average came in at $106.9 million for Q1 2026 at Immunic, up from $32.4 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $144.5 million in Q1 2022 to a low of $30.7 million in Q1 2025.
• The 5-year median for Assets Average is $79.2 million (2024), against an average of $86.1 million.
• Across the five-year window, Assets Average plunged 61.26% in 2025 and surged 248.3% in 2026, its largest moves.
• Immunic's Assets Average stood at $124.4 million in 2022, then tumbled by 51.26% to $60.6 million in 2023, then slipped by 12.9% to $52.8 million in 2024, then sank by 38.7% to $32.4 million in 2025, then jumped by 230.15% to $106.9 million in 2026.
• The last three Assets Average figures came in at $106.9 million (Q1 2026), $32.4 million (Q4 2025), and $51.1 million (Q3 2025), per Business Quant data.